BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23159193)

  • 1. How should we manage oral leukoplakia?
    Kumar A; Cascarini L; McCaul JA; Kerawala CJ; Coombes D; Godden D; Brennan PA
    Br J Oral Maxillofac Surg; 2013 Jul; 51(5):377-83. PubMed ID: 23159193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of potentially malignant disorders: evidence and critique.
    Lodi G; Porter S
    J Oral Pathol Med; 2008 Feb; 37(2):63-9. PubMed ID: 18197849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management.
    Thomson PJ; Wylie J
    Int J Oral Maxillofac Surg; 2002 Apr; 31(2):145-53. PubMed ID: 12102411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment outcome of oral premalignant lesions.
    Holmstrup P; Vedtofte P; Reibel J; Stoltze K
    Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral medicine 8. Leukoplakia of the oral mucosa].
    Schepman KP; van der Meij EH; de Visscher JG
    Ned Tijdschr Tandheelkd; 2013; 120(7-8):384-90. PubMed ID: 23923441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
    Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
    J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
    Schepman KP; van der Meij EH; Smeele LE; van der Waal I
    Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis and treatment of precancerous lesions.
    van der Waal I
    FDI World; 1995; 4(2):6-9. PubMed ID: 9552676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy.
    Kuribayashi Y; Tsushima F; Sato M; Morita K; Omura K
    J Oral Pathol Med; 2012 Oct; 41(9):682-8. PubMed ID: 22697318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative verrucous leukoplakia: an elusive disorder.
    Parashar P
    J Evid Based Dent Pract; 2014 Jun; 14 Suppl():147-53.e1. PubMed ID: 24929599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there any benefit in surgery for potentially malignant disorders of the oral cavity?
    Balasundaram I; Payne KF; Al-Hadad I; Alibhai M; Thomas S; Bhandari R
    J Oral Pathol Med; 2014 Apr; 43(4):239-44. PubMed ID: 23750566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of relationship between risk factors of malignant transformation of oral leukoplakia and the LSCP system].
    Sun Z; Gong Y; Huang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):364-6. PubMed ID: 11769652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of potentially malignant oral disorders.
    De Silva HL
    Ann R Australas Coll Dent Surg; 2012 Apr; 21():60-2. PubMed ID: 24783828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
    Gao Y; Guo ZL; Luo HY; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
    Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM
    J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
    Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA content as a prognostic marker in patients with oral leukoplakia.
    Sudbø J; Kildal W; Risberg B; Koppang HS; Danielsen HE; Reith A
    N Engl J Med; 2001 Apr; 344(17):1270-8. PubMed ID: 11320386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leukoplakia and erythroplakia--two orale precursor lesions].
    Grajewski S; Groneberg D
    Laryngorhinootologie; 2009 Oct; 88(10):666-72; quiz 673-5. PubMed ID: 19813163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The malignant transformation of leukoplakia of the oral cavity. A review of the literature and clinical case reports].
    Colella G; De Luca F; Lanza A; Tartaro GP
    Minerva Stomatol; 1995 Jun; 44(6):291-300. PubMed ID: 7476784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of oral leukoplakia by laser surgery: relation between recurrence and malignant transformation and clinicopathological features.
    Ishii J; Fujita K; Munemoto S; Komori T
    J Clin Laser Med Surg; 2004 Feb; 22(1):27-33. PubMed ID: 15117484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.